The long COVID treatments in the trials target autonomic nervous system dysregulation, which triggers some of the most burdensome symptoms.
Quick takes: Long-COVID treatment, SARS-CoV-2 biosafety, expanded airport pathogen sampling
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows